Cite

HARVARD Citation

    Labenz, C. et al. (2019). Raised serum Interleukin‐6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy. Alimentary pharmacology & therapeutics. 50 (10), pp. 1112-1119. [Online]. 
  
Back to record